Maine Medical Center is a 637-licensed-bed teaching hospital for Tufts University School of Medicine, and previously Robert Larner College of Medicine, located at 22 Bramhall Street in Portland, Maine, United States, with a staff of over 6,000.

There are 637 beds in Maine Medical Center-Bramhall Campus.

During the past decade, Maine Medical Center-Bramhall Campus conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 30 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 11 clinical trials were completed. i.e. 52.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Medical Center-Bramhall Campus" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "Gynecologic Oncology Group" with 17 trials sponsored, "NRG Oncology" with 10 trials sponsored, "GOG Foundation" with 5 trials sponsored and "Alliance for Clinical Trials in Oncology" with 5 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Center-Bramhall Campus" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Maine Medical Center-Bramhall Campus" are "Recurrent Ovarian Carcinoma" (8 trials), "Endometrial Clear Cell Adenocarcinoma" (7 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials), "Recurrent Primary Peritoneal Carcinoma" (7 trials) and "Endometrial Serous Adenocarcinoma" (6 trials). Many other conditions were trialed in "Maine Medical Center-Bramhall Campus" in a lesser frequency.

Most popular intervention types in "Maine Medical Center-Bramhall Campus" are "Other" (50 trials), "Drug" (47 trials), "Radiation" (30 trials), "Procedure" (24 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (30 trials), "Laboratory Biomarker Analysis" (22 trials), "Questionnaire Administration" (21 trials), "Paclitaxel" (15 trials) and "Carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Maine Medical Center-Bramhall Campus" are 40 trials for "Female" genders, 24 trials for "All" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Maine Medical Center-Bramhall Campus". undefined are not yet recruiting, 18 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Maine Medical Center-Bramhall Campus, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Medical Center-Bramhall Campus, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".